<!DOCTYPE html> <html lang="en"> <head> <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"> <meta charset="utf-8"> <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <title> Sander Roberti </title> <meta name="author" content="Sander Roberti"> <meta name="description" content=""> <link rel="stylesheet" href="/assets/css/bootstrap.min.css?a4b3f509e79c54a512b890d73235ef04"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/mdbootstrap@4.20.0/css/mdb.min.css" integrity="sha256-jpjYvU3G3N6nrrBwXJoVEYI/0zw8htfFnhT9ljN3JJw=" crossorigin="anonymous"> <link defer rel="stylesheet" href="/assets/css/academicons.min.css?f0b7046b84e425c55f3463ac249818f5"> <link defer rel="stylesheet" href="/assets/css/scholar-icons.css?62b2ac103a88034e6882a5be5f3e2772"> <link defer rel="stylesheet" type="text/css" href="https://fonts.googleapis.com/css?family=Roboto:300,400,500,700|Roboto+Slab:100,300,400,500,700|Material+Icons&amp;display=swap"> <link defer rel="stylesheet" href="/assets/css/jekyll-pygments-themes-github.css?591dab5a4e56573bf4ef7fd332894c99" media="" id="highlight_theme_light"> <link rel="shortcut icon" href="data:image/svg+xml,&lt;svg%20xmlns=%22http://www.w3.org/2000/svg%22%20viewBox=%220%200%20100%20100%22&gt;&lt;text%20y=%22.9em%22%20font-size=%2290%22&gt;%E2%9A%9B%EF%B8%8F&lt;/text&gt;&lt;/svg&gt;"> <link rel="stylesheet" href="/assets/css/main.css?d41d8cd98f00b204e9800998ecf8427e"> <link rel="canonical" href="https://sanderroberti.com/"> <script src="/assets/js/theme.js?9a0c749ec5240d9cda97bc72359a72c0"></script> <link defer rel="stylesheet" href="/assets/css/jekyll-pygments-themes-native.css?5847e5ed4a4568527aa6cfab446049ca" media="none" id="highlight_theme_dark"> <script>
    initTheme();
  </script> </head> <body class="fixed-top-nav "> <header> <nav id="navbar" class="navbar navbar-light navbar-expand-sm fixed-top" role="navigation"> <div class="container"> <div class="navbar-brand social"> <a href="mailto:%63%6F%6E%74%61%63%74@%73%61%6E%64%65%72%72%6F%62%65%72%74%69.%63%6F%6D" title="email"><i class="fa-solid fa-envelope"></i></a> <a href="https://github.com/sanderroberti" title="GitHub" rel="external nofollow noopener" target="_blank"><i class="fa-brands fa-github"></i></a> <a href="https://www.linkedin.com/in/sanderroberti" title="LinkedIn" rel="external nofollow noopener" target="_blank"><i class="fa-brands fa-linkedin"></i></a> <a href="https://orcid.org/0000-0002-6275-7442" title="ORCID" rel="external nofollow noopener" target="_blank"><i class="ai ai-orcid"></i></a> <a href="https://scholar.google.com/citations?user=ii4M7kkAAAAJ" title="Google Scholar" rel="external nofollow noopener" target="_blank"><i class="ai ai-google-scholar"></i></a> </div> <button class="navbar-toggler collapsed ml-auto" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation"> <span class="sr-only">Toggle navigation</span> <span class="icon-bar top-bar"></span> <span class="icon-bar middle-bar"></span> <span class="icon-bar bottom-bar"></span> </button> <div class="collapse navbar-collapse text-right" id="navbarNav"> <ul class="navbar-nav ml-auto flex-nowrap"> <li class="nav-item active"> <a class="nav-link" href="/">about <span class="sr-only">(current)</span> </a> </li> <li class="nav-item "> <a class="nav-link" href="/publications/">publications </a> </li> <li class="nav-item "> <a class="nav-link" href="/repositories/">repositories </a> </li> <li class="toggle-container"> <button id="light-toggle" title="Change theme"> <i class="ti ti-sun-moon" id="light-toggle-system"></i> <i class="ti ti-moon-filled" id="light-toggle-dark"></i> <i class="ti ti-sun-filled" id="light-toggle-light"></i> </button> </li> </ul> </div> </div> </nav> <progress id="progress" value="0"> <div class="progress-container"> <span class="progress-bar"></span> </div> </progress> </header> <div class="container mt-5" role="main"> <div class="post"> <header class="post-header"> <h1 class="post-title"> <span class="font-weight-bold">Sander</span> Roberti </h1> <p class="desc">Biostatistics Branch &amp; Radiation Epidemiology Branch, National Cancer Institute, National Institutes of Health</p> </header> <article> <div class="profile float-right"> <figure> <picture> <source class="responsive-img-srcset" srcset="/assets/img/profpic2-480.webp 480w,/assets/img/profpic2-800.webp 800w,/assets/img/profpic2-1400.webp 1400w," type="image/webp" sizes="(min-width: 930px) 270.0px, (min-width: 576px) 30vw, 95vw"> <img src="/assets/img/profpic2.jpg?720121eebcce05664787c01c2b8cf2ff" class="img-fluid z-depth-1 rounded" width="100%" height="auto" alt="profpic2.jpg" loading="eager" onerror="this.onerror=null; $('.responsive-img-srcset').remove();"> </source></picture> </figure> <div class="more-info"> <p>Room 7E134</p> <p>9609 Medical Center Drive</p> <p>Rockville, MD 20850</p> <p>United States of America</p> </div> </div> <div class="clearfix"> <p>I am currently a Postdoctoral Fellow in the Biostatistics Branch and the Radiation Epidemiology Branch of the National Cancer Institute. There I am working on studies of radiation exposure following the Chernobyl nuclear reactor accident and modeling the natural history of thyroid nodules under the mentorship of <a href="https://dceg.cancer.gov/about/staff-directory/cheung-li" rel="external nofollow noopener" target="_blank">Li Cheung</a> and <a href="https://dceg.cancer.gov/about/staff-directory/cahoon-elizabeth" rel="external nofollow noopener" target="_blank">Elizabeth Cahoon</a>.</p> <p>Before joining NCI, my PhD work focused on new methods for assessing the risk of developing a second tumor after exposure to therapeutic radiation. These methods, incorporating the radiation dose to every point in the organ at risk of developing such a tumor, are expected to increase the accuracy of risk predictions. Furthermore, they should be able to better discriminate between different radiotherapy treatment plans. Using these methods, I developed an <a href="https://sanderroberti.shinyapps.io/absoluteBCrisk/" rel="external nofollow noopener" target="_blank">absolute risk prediction model</a> for breast cancer among female survivors of Hodgkin lymphoma. Besides this research project, I was a lecturer for the yearly Basic Medical Statistics course, including lectures as well as computer practicals. Finally, I was involved in other research projects as a statistical consultant.</p> <p>Prior to my doctoral research I obtained a MSc in Mathematics with a focus on statistics and probability, with a master’s thesis in biostatistics.</p> </div> <h2> <a href="/publications/" style="color: inherit">selected publications</a> </h2> <div class="publications"> <ol class="bibliography"> <li> <div class="row"> <div id="robertiBuildingAbsoluteBreast2025" class="col-sm-10"> <div class="title">Building Absolute Breast Cancer Risk Prediction Models for Women Treated with Chest Radiation for Hodgkin Lymphoma</div> <div class="author"> <em>Sander Roberti</em>, <a href="https://www.nki.nl/research/find-a-researcher/groupleaders/floor-van-leeuwen/" rel="external nofollow noopener" target="_blank">Flora E van Leeuwen</a>, <a href="https://www.mhb-fontane.de/details-zu/michael-hauptmann.html" rel="external nofollow noopener" target="_blank">Michael Hauptmann</a>, and <a href="https://dceg.cancer.gov/about/staff-directory/pfeiffer-ruth" rel="external nofollow noopener" target="_blank">Ruth M Pfeiffer</a> </div> <div class="periodical"> <em>Journal of the Royal Statistical Society Series C: Applied Statistics</em>, Jan 2025 </div> <div class="periodical"> </div> <div class="links"> <a class="abstract btn btn-sm z-depth-0" role="button">Abs</a> <a href="https://doi.org/10.1093/jrsssc/qlae063" class="btn btn-sm z-depth-0" role="button" rel="external nofollow noopener" target="_blank">DOI</a> </div> <div class="abstract hidden"> <p>We built models to predict absolute breast cancer (BC) risk in women treated with radiotherapy for Hodgkin lymphoma (HL). We first estimated relative risks (RRs) for risk factors, including radiation dose to 10 breast segments to accommodate heterogeneity of treatment effects, using a case-control sample nested in an HL survivor cohort. To estimate RRs of case-control matching factors we developed novel weighting approaches. We then combined RRs with age-specific BC incidence and competing mortality rates from the HL survivor cohort and a population-based registry, accommodating differences between them. We compared the performance of models using segment-specific doses with using mean dose only.</p> </div> </div> </div> </li> <li> <div class="row"> <div id="robertiPredictionBreastCancer2025" class="col-sm-10"> <div class="title">Prediction of Breast Cancer Risk for Adolescents and Young Adults with Hodgkin Lymphoma</div> <div class="author"> <em>Sander Roberti</em>, <a href="https://www.nki.nl/research/find-a-researcher/groupleaders/floor-van-leeuwen/" rel="external nofollow noopener" target="_blank">Flora E van Leeuwen</a>, Ibrahima Diallo, Florent de Vathaire, Michael Schaapveld, Wendy M Leisenring, Rebecca M Howell, Gregory T Armstrong, Chaya S Moskowitz, Susan A Smith, Berthe M P Aleman, Inge M Krul, Nicola S Russell, <a href="https://dceg.cancer.gov/about/staff-directory/pfeiffer-ruth" rel="external nofollow noopener" target="_blank">Ruth M Pfeiffer</a>, and <a href="https://www.mhb-fontane.de/details-zu/michael-hauptmann.html" rel="external nofollow noopener" target="_blank">Michael Hauptmann</a> </div> <div class="periodical"> <em>JNCI: Journal of the National Cancer Institute</em>, Jan 2025 </div> <div class="periodical"> </div> <div class="links"> <a class="abstract btn btn-sm z-depth-0" role="button">Abs</a> <a href="https://doi.org/10.1093/jnci/djae274" class="btn btn-sm z-depth-0" role="button" rel="external nofollow noopener" target="_blank">DOI</a> </div> <div class="abstract hidden"> <p>Although female survivors of Hodgkin lymphoma (HL) have an increased risk of breast cancer (BC), no BC risk prediction model is available. We developed such models incorporating mean radiation dose to the breast or breast quadrant-specific radiation doses.Relative risks and age-specific incidence for BC and competing events (mortality or other subsequent cancer) were estimated from 1194 Dutch 5-year HL survivors, treated at ages 11-40 during 1965-2000. Predictors were doses to 10 breast segments or mean breast radiation dose, BC family history, year of and age at HL diagnosis, and ages at menopause and first live birth. Models were independently validated using US Childhood Cancer Survivor Study cohort participants.Predicted absolute BC risks 25 years after HL diagnosis ranged from 1.0% for survivors diagnosed at ages 20-24 with less than 10 Gy mean breast radiation dose and who were menopausal 5 years after HL diagnosis, to 22.0% for survivors 25-29 years at diagnosis, with at least 25 Gy mean breast dose and no menopause within 5 years. In external validation, the observed/expected BC case ratio was 1.19 (95% confidence interval 0.97 to 1.47) for the breast segment-specific dose model, and 1.29 (1.05 to 1.60) for the mean breast dose model. The areas under the receiver operating characteristic curve were 0.68 (0.63 to 0.74) and 0.68 (0.62 to 0.73), respectively.Breast segment-specific or mean breast radiation dose with personal and clinical characteristics predicted absolute BC risk in HL survivors with moderate discrimination but good calibration, rendering the models useful for clinical decision-making.</p> </div> </div> </div> </li> <li> <div class="row"> <div id="robertiRadiationDosesBreast2025" class="col-sm-10"> <div class="title">Radiation Doses to the Breast and Predicted Breast Cancer Risk among Patients Treated for Hodgkin Lymphoma with Modern Radiotherapy</div> <div class="author"> <em>Sander Roberti</em>, Nicola S. Russell, <a href="https://dceg.cancer.gov/about/staff-directory/pfeiffer-ruth" rel="external nofollow noopener" target="_blank">Ruth M. Pfeiffer</a>, Inge M. Krul, Florent Vathaire, Cristina Veres, Ibrahima Diallo, Cécile P. M. Janus, Joan Penninkhof, René Vernhout, André Buchali, Eyck Blank, <a href="https://www.nki.nl/research/find-a-researcher/groupleaders/floor-van-leeuwen/" rel="external nofollow noopener" target="_blank">Flora E. van Leeuwen</a>, and <a href="https://www.mhb-fontane.de/details-zu/michael-hauptmann.html" rel="external nofollow noopener" target="_blank">Michael Hauptmann</a> </div> <div class="periodical"> <em>International Journal of Radiation Oncology, Biology, Physics</em>, Jan 2025 </div> <div class="periodical"> </div> <div class="links"> <a href="https://doi.org/10.1016/j.ijrobp.2024.12.016" class="btn btn-sm z-depth-0" role="button" rel="external nofollow noopener" target="_blank">DOI</a> </div> </div> </div> </li> <li> <div class="row"> <div id="robertiRadiotherapyrelatedDoseIrradiated2022" class="col-sm-10"> <div class="title">Radiotherapy-Related Dose and Irradiated Volume Effects on Breast Cancer Risk among Hodgkin Lymphoma Survivors</div> <div class="author"> <em>Sander Roberti</em>, <a href="https://www.nki.nl/research/find-a-researcher/groupleaders/floor-van-leeuwen/" rel="external nofollow noopener" target="_blank">Flora E van Leeuwen</a>, Cécile M Ronckers, Inge M Krul, Florent de Vathaire, Cristina Veres, Ibrahima Diallo, Cécile P M Janus, Berthe M P Aleman, Nicola S Russell, and <a href="https://www.mhb-fontane.de/details-zu/michael-hauptmann.html" rel="external nofollow noopener" target="_blank">Michael Hauptmann</a> </div> <div class="periodical"> <em>JNCI: Journal of the National Cancer Institute</em>, Sep 2022 </div> <div class="periodical"> </div> <div class="links"> <a class="abstract btn btn-sm z-depth-0" role="button">Abs</a> <a href="https://doi.org/10.1093/jnci/djac125" class="btn btn-sm z-depth-0" role="button" rel="external nofollow noopener" target="_blank">DOI</a> </div> <div class="abstract hidden"> <p>Background: Breast cancer (BC) risk is increased among Hodgkin lymphoma (HL) survivors treated with chest radiotherapy. Case-control studies showed a linear radiation dose-response relationship for estimated dose to the breast tumor location. However, these relative risks cannot be used for absolute risk prediction of BC anywhere in the breasts. Furthermore, the independent and joint effects of radiation dose and irradiated volumes are unclear. Therefore, we examined the effects of mean breast dose and various dose-volume parameters on BC risk in HL patients. Methods: We conducted a nested casecontrol study of BC among 5-year HL survivors (173 case patients, 464 matched control patients). Dose-volume histograms were obtained from reconstructed voxel-based 3-dimensional dose distributions. Summary parameters of dose-volume histograms were studied next to mean and median breast dose, Gini index, and the new dose metric mean absolute difference of dose, using categorical and linear excess odds ratio (EOR) models. Interactions between dose-volume parameters and mean dose were also examined. Results: Statistically significant linear dose-response relationships were observed for mean breast dose (EOR per Gy \frac14 0.19, 95% confidence interval [CI] \frac14 0.05 to 1.06) and median dose (EOR/Gy \frac14 0.06, 95% CI \frac14 0.02 to 0.19), with no statistically significant curvature. All metrics except Gini and mean absolute difference were positively correlated with each other. These metrics all showed similar patterns of dose-response that were no longer statistically significant when adjusting for mean dose. No statistically significant modification of the effect of mean dose was observed. Conclusion: Mean breast dose predicts subsequent BC risk in long-term HL survivors.</p> </div> </div> </div> </li> <li> <div class="row"> <div id="robertiBiasCorrectionEstimates2021" class="col-sm-10"> <div class="title">Bias Correction for Estimates from Linear Excess Relative Risk Models in Small Case-Control Studies</div> <div class="author"> <em>Sander Roberti</em>, <a href="https://www.nki.nl/research/find-a-researcher/groupleaders/floor-van-leeuwen/" rel="external nofollow noopener" target="_blank">Flora E. van Leeuwen</a>, <a href="https://www.mhb-fontane.de/details-zu/michael-hauptmann.html" rel="external nofollow noopener" target="_blank">Michael Hauptmann</a>, and <a href="https://dceg.cancer.gov/about/staff-directory/pfeiffer-ruth" rel="external nofollow noopener" target="_blank">Ruth M. Pfeiffer</a> </div> <div class="periodical"> <em>Statistics in Medicine</em>, Aug 2021 </div> <div class="periodical"> </div> <div class="links"> <a href="https://doi.org/10.1002/sim.9158" class="btn btn-sm z-depth-0" role="button" rel="external nofollow noopener" target="_blank">DOI</a> </div> </div> </div> </li> </ol> </div> </article> </div> </div> <footer class="fixed-bottom" role="contentinfo"> <div class="container mt-0"> © Copyright 2025 Sander Roberti. Last updated: January 18, 2025. </div> </footer> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.0/dist/jquery.min.js" integrity="sha256-/xUj+3OJU5yExlq6GSYGSHk7tPXikynS7ogEvDej/m4=" crossorigin="anonymous"></script> <script src="/assets/js/bootstrap.bundle.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/mdbootstrap@4.20.0/js/mdb.min.js" integrity="sha256-NdbiivsvWt7VYCt6hYNT3h/th9vSTL4EDWeGs5SN3DA=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/masonry-layout@4.2.2/dist/masonry.pkgd.min.js" integrity="sha256-Nn1q/fx0H7SNLZMQ5Hw5JLaTRZp0yILA/FRexe19VdI=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/imagesloaded@5.0.0/imagesloaded.pkgd.min.js" integrity="sha256-htrLFfZJ6v5udOG+3kNLINIKh2gvoKqwEhHYfTTMICc=" crossorigin="anonymous"></script> <script defer src="/assets/js/masonry.js?a0db7e5d5c70cc3252b3138b0c91dcaf" type="text/javascript"></script> <script defer src="https://cdn.jsdelivr.net/npm/medium-zoom@1.1.0/dist/medium-zoom.min.js" integrity="sha256-ZgMyDAIYDYGxbcpJcfUnYwNevG/xi9OHKaR/8GK+jWc=" crossorigin="anonymous"></script> <script defer src="/assets/js/zoom.js?85ddb88934d28b74e78031fd54cf8308"></script> <script src="/assets/js/no_defer.js?2781658a0a2b13ed609542042a859126"></script> <script defer src="/assets/js/common.js?e0514a05c5c95ac1a93a8dfd5249b92e"></script> <script defer src="/assets/js/copy_code.js?12775fdf7f95e901d7119054556e495f" type="text/javascript"></script> <script defer src="/assets/js/jupyter_new_tab.js?d9f17b6adc2311cbabd747f4538bb15f"></script> <script async src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script async src="https://badge.dimensions.ai/badge.js"></script> <script defer type="text/javascript" id="MathJax-script" src="https://cdn.jsdelivr.net/npm/mathjax@3.2.2/es5/tex-mml-chtml.js" integrity="sha256-MASABpB4tYktI2Oitl4t+78w/lyA+D7b/s9GEP0JOGI=" crossorigin="anonymous"></script> <script src="/assets/js/mathjax-setup.js?a5bb4e6a542c546dd929b24b8b236dfd"></script> <script defer src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6" crossorigin="anonymous"></script> <script defer src="/assets/js/progress-bar.js?2f30e0e6801ea8f5036fa66e1ab0a71a" type="text/javascript"></script> <script src="/assets/js/vanilla-back-to-top.min.js?f40d453793ff4f64e238e420181a1d17"></script> <script>
    addBackToTop();
  </script> </body> </html>